Company Report for the Third Quarter of 2024 (after correction)

SZSINov 30 00:00 · Announcements

Announcement on additional information to the 2024 Third Quarter Report

SZSINov 30 00:00 · Announcements

Express News | Lionco Pharmaceutical Group received a regulatory work letter from the Shanghai Stock Exchange: requiring an explanation of the specific reasons for the significant increase in the stock preparation business in the first three quarters.

BreakingsNov 22 21:25

Express News | lionco pharmaceutical group: The injection of cefuroxime sodium passed the generic consistency evaluation.

BreakingsNov 5 15:52

Lingkang Pharmaceutical: Third Quarter Report 2024

SZSIOct 31 00:00 · Announcements

Third Quarter Report 2024

SZSIOct 31 00:00 · Announcements